Group One Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-48,395
Closed -$363K 5233
2016
Q1
$309K Sell
48,395
-137,498
-74% -$771K ﹤0.01% 2034
2015
Q4
$1.16M Sell
185,893
-70,830
-28% -$465K 0.01% 1216
2015
Q3
$1.5M Buy
256,723
+170,254
+197% +$1.31M 0.02% 976
2015
Q2
$715K Sell
86,469
-336,903
-80% -$2.98M 0.01% 1488
2015
Q1
$3.49M Sell
423,372
-413,044
-49% -$3.05M 0.05% 380
2014
Q4
$5.75M Buy
836,416
+20,571
+3% +$129K 0.09% 243
2014
Q3
$4.41M Buy
815,845
+46,424
+6% +$271K 0.07% 346
2014
Q2
$4.9M Buy
769,421
+393,848
+105% +$2.71M 0.08% 299
2014
Q1
$3.03M Sell
375,573
-603,173
-62% -$4.7M 0.05% 428
2013
Q4
$6.67M Buy
978,746
+810,967
+483% +$4.38M 0.1% 187
2013
Q3
$3.09M Buy
167,779
+118,986
+244% +$2.31M 0.06% 353
2013
Q2
$853K Buy
+48,793
New +$865K 0.02% 929

Other funds holding ARIA

Group One Trading's ARIA Position: Q2 2016 in Review

Group One Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 48,395 shares — an estimated $363K sold.

Group One Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $6.67M in Q4 2013. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • Group One Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Group One Trading sold 48,395 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $363K.
  • Group One Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Group One Trading's Ariad Pharmaceuticals Inc position peaked at $6.67M in Q4 2013.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Group One Trading's 13F filing for Q2 2016, filed 12 Aug 2016.